Correlation Between Vivos Therapeutics and Clearpoint Neuro

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Clearpoint Neuro, you can compare the effects of market volatilities on Vivos Therapeutics and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Clearpoint Neuro.

Diversification Opportunities for Vivos Therapeutics and Clearpoint Neuro

-0.41

Correlation Coefficient

Vivos Therapeutics  Clearpoint Neuro

Very good diversification

The 3 months correlation between Vivos and Clearpoint is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Clearpoint Neuro

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Clearpoint Neuro. But the stock apears to be less risky and, when comparing its historical volatility, Vivos Therapeutics is 2.29 times less risky than Clearpoint Neuro. The stock trades about -0.27 of its potential returns per unit of risk. The Clearpoint Neuro is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  1,064  in Clearpoint Neuro on August 26, 2025 and sell it today you would earn a total of  376.00  from holding Clearpoint Neuro or generate 35.34% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Clearpoint Neuro

Vivos Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Clearpoint Neuro

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Clearpoint Neuro are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Clearpoint Neuro unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vivos Therapeutics and Clearpoint Neuro

The main advantage of trading using opposite Vivos Therapeutics and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.

The idea behind Vivos Therapeutics and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.